Ajibowo Abimbola O, Okobi Okelue E, Emore Erhieyovbe, Soladoye Elizabeth, Sike Cherechi G, Odoma Victor A, Bakare Ibrahim O, Kolawole Olasunkanmi A, Afolayan Adebola, Okobi Emeka, Chukwu Chinyereadaeze
Internal Medicine, Lugansk Medical University, Lugansk, UKR.
Family Medicine, Medficient Health Systems, Laurel, USA.
Cureus. 2023 Jul 1;15(7):e41252. doi: 10.7759/cureus.41252. eCollection 2023 Jul.
Cardiorenal syndrome (CRS) is a condition characterized by the intricate two-way relationship between the heart and kidneys, which can lead to acute or chronic dysfunction in these organs. The interplay between cardiorenal connectors and both hemodynamic and non-hemodynamic factors is crucial to understanding this syndrome. The clinical importance of these interactions is evident in the changes observed in hemodynamic factors, neurohormonal markers, and inflammatory processes. Identifying and understanding biomarkers associated with CRS is valuable for early detection and enabling intervention before significant organ dysfunction occurs. This comprehensive review focuses on the clinical significance of biomarkers in the diagnosis, prognosis, and management of CRS. Finally, it highlights the necessity for further advancements in managing this condition.
心肾综合征(CRS)是一种以心脏和肾脏之间复杂的双向关系为特征的病症,可导致这些器官的急性或慢性功能障碍。心肾连接物与血流动力学和非血流动力学因素之间的相互作用对于理解该综合征至关重要。这些相互作用在血流动力学因素、神经激素标志物和炎症过程的变化中所观察到的情况中体现出临床重要性。识别和理解与CRS相关的生物标志物对于早期检测以及在出现明显器官功能障碍之前进行干预很有价值。这篇综述聚焦于生物标志物在CRS诊断、预后和管理中的临床意义。最后,强调了在管理这种病症方面进一步取得进展的必要性。